FCM Releases Letter To Fellow MindMed Shareholders Highlighting Board And Management’s Track Record Of Shareholder Value Destruction
MindMed Board has Presided over Botched Regulatory Strategies, Outsized Expenses, Soaring Executive Compensation, and Value Destructive Financings
FCM's Four Highly Qualified Director Nominees to Bring